The DOJ's Focus on Clinical Trial Enforcement: An Ounce of Prevention Is Better Than an Enforcement Action Cure | Orrick, Herrington & Sutcliffe LLP

In early April, the U.S. Department of Justice (DOJ) Civil Division’s Consumer Protection Branch (CPB) published its first-ever “Recent Highlights” report. The report provides...

Related Keywords

United States ,Arung Rao , ,Civil Division Consumer Protection Branch ,Tellus Clinical Research ,National Institutes Of Health ,Drug Administration ,Renal Care Grp Inc ,Unlimited Medical Research ,Us Department Of Justice ,Herrington Sutcliffe ,Civil Division ,Consumer Protection Branch ,False Claims Act ,Deputy Assistant Attorney General Arun ,Medical Research ,Clinical Research ,Enforcement Priority Means ,Companies Involved ,National Institutes ,Care Grp ,